Breaking News Instant updates and real-time market news.

VRTU

Virtusa

$29.97 /

-2.29 (-7.10%)

17:20
05/28/20
05/28
17:20
05/28/20
17:20

Virtusa files automatic common stock offering

VRTU Virtusa
$29.97 /

-2.29 (-7.10%)

05/14/20 William Blair
Virtusa downgraded to Market Perform from Outperform at William Blair
02/07/20 Needham
Virtusa price target raised to $56 from $48 at Needham
01/07/20 Barrington
Adtalem, Tivity, Virtusa among Barrington's Best Ideas for 2020
01/06/20 Wedbush
Wedbush says buy Virtusa on weakness as market 'overreacts' to Citi renewal

TODAY'S FREE FLY STORIES

Hot Stocks
Kirkland Lake Gold reports Q2 gold production of 329,770 ounces » 07:29
07/07/20
07/07
07:29
07/07/20
07:29
KL

Kirkland Lake Gold

$41.92 /

+0.285 (+0.68%)

Kirkland Lake Gold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

06/11/20
Fly Intel: Top five analyst upgrades
06/11/20 Roth Capital
Kirkland Lake upgraded to Buy on higher gold prices at Roth Capital
06/11/20 Roth Capital
Kirkland Lake Gold upgraded to Buy from Neutral at Roth Capital
05/29/20 BMO Capital
Kirkland Lake Gold upgraded to Outperform from Market Perform at BMO Capital
KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

Downgrade
Guggenheim downgrades Bellus Health to Neutral after 'disappointing' cough trial » 07:26
07/07/20
07/07
07:26
07/07/20
07:26
BLU

Bellus Health

$3.45 /

-8.56 (-71.27%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLU Bellus Health
$3.45 /

-8.56 (-71.27%)

BLU Bellus Health
$3.45 /

-8.56 (-71.27%)

06:12 Today Guggenheim
Bellus Health downgraded to Neutral from Buy at Guggenheim
07/06/20 Jefferies
Jefferies cuts Bellus target to $6, sees potential for 'meaningful upside'
07/06/20 Mackie
Bellus Health downgraded to Hold from Speculative Buy at Mackie
07/06/20 H.C. Wainwright
H.C. Wainwright reiterates $28 target on Bellus despite Phase 2 miss
  • 05
    Sep
BLU Bellus Health
$3.45 /

-8.56 (-71.27%)

Conference/Events
Morgan Stanley semiconductors analysts to hold a webinar » 07:25
07/07/20
07/07
07:25
07/07/20
07:25

Semiconductors Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS mining analysts to hold analyst/industry conference call » 07:25
07/07/20
07/07
07:25
07/07/20
07:25

Mining Analysts discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Sangamo initiated with a Buy at SunTrust » 07:24
07/07/20
07/07
07:24
07/07/20
07:24
SGMO

Sangamo

$9.82 /

+0.18 (+1.87%)

, BIIB

Biogen

$269.55 /

+4.2 (+1.58%)

SunTrust analyst Nicole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

06:53 Today SunTrust
Sangamo initiated with a Buy at SunTrust
06/22/20 H.C. Wainwright
Sangamo price target lowered to $14 from $16 at H.C. Wainwright
02/28/20 William Blair
Biogen deal with Sangamo unlikely to have near-term impact, says William Blair
02/03/20 Evercore ISI
Evercore ISI downgrades Crispr Therapeutics, questions relative valuation
BIIB Biogen
$269.55 /

+4.2 (+1.58%)

06/22/20 RBC Capital
Biogen price target lowered to $273 from $303 at RBC Capital
06/22/20 Barclays
Barclays downgrades Biogen to Equal Weight on 'mounting uncertainties'
06/22/20 Barclays
Biogen downgraded to Equal Weight from Overweight at Barclays
06/19/20 Citi
Biogen patent loss a 'major setback,' says Citi
SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

Downgrade
Total Access Communications downgraded to Sell from Neutral at Citi » 07:20
07/07/20
07/07
07:20
07/07/20
07:20
TACYY

Total Access Communications

$0.00 /

+ (+0.00%)

Citi analyst Arthur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TACYY Total Access Communications
$0.00 /

+ (+0.00%)

05/05/20 Goldman Sachs
Total Access downgraded to Sell from Neutral at Goldman Sachs
03/24/20 Goldman Sachs
Total Access Communications upgraded to Neutral from Sell at Goldman Sachs
02/19/20 JPMorgan
Total Access downgraded to Underweight from Overweight at JPMorgan
Hot Stocks
Corvus Pharmaceuticals initiates study to investigate immunotherapy for COVID-19 » 07:19
07/07/20
07/07
07:19
07/07/20
07:19
CRVS

Corvus Pharmaceuticals

$2.76 /

+0.21 (+8.24%)

Corvus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

03/10/20 H.C. Wainwright
Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright
12/09/19 Mizuho
Corvus pipeline updates 'can only be additive,' says Mizuho
09/12/19 Mizuho
Mizuho starts Corvus Pharmaceuticals with Buy rating, $7 price target
09/11/19 Mizuho
Corvus Pharmaceuticals initiated with a Buy at Mizuho
CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

Recommendations
Netflix price target raised to $550 from $465 at Credit Suisse » 07:19
07/07/20
07/07
07:19
07/07/20
07:19
NFLX

Netflix

$494.09 /

+17.78 (+3.73%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

07/06/20
Fly Intel: Top five analyst downgrades
07/06/20 Canaccord
Netflix content leadership poised to persist, says Canaccord
07/06/20 Imperial Capital
Netflix downgraded to In-Line from Outperform at Imperial Capital
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

Hot Stocks
Regeneron: REGN-COV2 initial doses may be ready as early as end of summer » 07:17
07/07/20
07/07
07:17
07/07/20
07:17
REGN

Regeneron

$626.65 /

+5.89 (+0.95%)

Regeneron began scaling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$626.65 /

+5.89 (+0.95%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
REGN Regeneron
$626.65 /

+5.89 (+0.95%)

  • 27
    May
REGN Regeneron
$626.65 /

+5.89 (+0.95%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

Downgrade
Benchmark downgrades ACM Research to Hold following 327% year-to-date rally » 07:17
07/07/20
07/07
07:17
07/07/20
07:17
ACMR

ACM Research

$80.87 /

+15.11 (+22.98%)

Benchmark analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

06:23 Today Benchmark
ACM Research downgraded to Hold from Buy at Benchmark
06/22/20 Stifel
ACM Research downgraded to Hold from Buy at Stifel
05/19/20 Roth Capital
ACM Research price target raised to $80 from $60 at Roth Capital
05/07/20 Stifel
ACM Research price target raised to $50 from $28 at Stifel
ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

  • 15
    Aug
ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

Initiation
Huize initiated with a Buy at Citi » 07:17
07/07/20
07/07
07:17
07/07/20
07:17
HUIZ

Huize

$8.10 /

+0.69 (+9.31%)

Citi analyst Michelle Ma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUIZ Huize
$8.10 /

+0.69 (+9.31%)

  • 12
    Feb
HUIZ Huize
$8.10 /

+0.69 (+9.31%)

Hot Stocks
Tonix Pharmaceuticals announces intent to purchase Massachusetts R&D facility » 07:15
07/07/20
07/07
07:15
07/07/20
07:15
TNXP

Tonix Pharmaceuticals

$0.59 /

-0.01 (-1.67%)

Tonix Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNXP Tonix Pharmaceuticals
$0.59 /

-0.01 (-1.67%)

TNXP Tonix Pharmaceuticals
$0.59 /

-0.01 (-1.67%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
TNXP Tonix Pharmaceuticals
$0.59 /

-0.01 (-1.67%)

  • 16
    Jul
TNXP Tonix Pharmaceuticals
$0.59 /

-0.01 (-1.67%)

Upgrade
Yokohama upgraded to Buy from Neutral at Citi » 07:15
07/07/20
07/07
07:15
07/07/20
07:15
YORUY

Yokohama

$0.00 /

+ (+0.00%)

Citi analyst Arifumi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Cinedigm initiated with a Speculative Buy at Benchmark » 07:14
07/07/20
07/07
07:14
07/07/20
07:14
CIDM

Cinedigm

$2.07 /

-0.02 (-0.96%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CIDM Cinedigm
$2.07 /

-0.02 (-0.96%)

CIDM Cinedigm
$2.07 /

-0.02 (-0.96%)

06:54 Today Benchmark
Cinedigm initiated with a Speculative Buy at Benchmark
CIDM Cinedigm
$2.07 /

-0.02 (-0.96%)

Recommendations
New Wave could offer a 'bit more' for Sina, says Citi » 07:12
07/07/20
07/07
07:12
07/07/20
07:12
SINA

Sina

$40.54 /

+3.86 (+10.52%)

, WB

Weibo

$39.79 /

+6.1 (+18.11%)

Citi analyst Alicia Yap…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SINA Sina
$40.54 /

+3.86 (+10.52%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

SINA Sina
$40.54 /

+3.86 (+10.52%)

02/27/20 BOCOM
Sina downgraded to Neutral from Buy at BOCOM
12/05/19 Goldman Sachs
Sina downgraded to Neutral from Buy at Goldman Sachs
08/21/19 BOCOM
Sina upgraded to Buy from Neutral at BOCOM
08/05/19 Jefferies
Sina assumed with a Hold at Jefferies
WB Weibo
$39.79 /

+6.1 (+18.11%)

05/20/20 HSBC
Weibo price target lowered to $34.50 from $38 at HSBC
05/06/20 OTR Global
Weibo downgraded to Negative from Mixed at OTR Global
04/22/20 Barclays
Weibo downgraded to Equal Weight from Overweight at Barclays
04/01/20
Weibo participates in a conference call with Benchmark
SINA Sina
$40.54 /

+3.86 (+10.52%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

SINA Sina
$40.54 /

+3.86 (+10.52%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

Hot Stocks
Myriad Genetics announces publication of two riskScore analyses » 07:11
07/07/20
07/07
07:11
07/07/20
07:11
MYGN

Myriad Genetics

$11.85 /

+0.325 (+2.82%)

Myriad Genetics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYGN Myriad Genetics
$11.85 /

+0.325 (+2.82%)

MYGN Myriad Genetics
$11.85 /

+0.325 (+2.82%)

06/11/20 Piper Sandler
Palmetto coverage language unclear about Myriad's GeneSight, says Piper Sandler
05/06/20 JPMorgan
Myriad Genetics price target lowered to $12 from $14 at JPMorgan
05/06/20 Piper Sandler
Myriad Genetics price target lowered to $14 from $20 at Piper Sandler
03/06/20 JPMorgan
Myriad Genetics price target lowered to $14 from $17 at JPMorgan
MYGN Myriad Genetics
$11.85 /

+0.325 (+2.82%)

MYGN Myriad Genetics
$11.85 /

+0.325 (+2.82%)

Recommendations
Malibu Boats price target raised to $58 from $48 at KeyBanc » 07:10
07/07/20
07/07
07:10
07/07/20
07:10
MBUU

Malibu Boats

$54.88 /

+3.5 (+6.81%)

KeyBanc analyst Brett…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MBUU Malibu Boats
$54.88 /

+3.5 (+6.81%)

MBUU Malibu Boats
$54.88 /

+3.5 (+6.81%)

06/11/20 SunTrust
Malibu Boats price target raised to $62 from $45 at SunTrust
06/08/20 B. Riley FBR
Malibu Boats price target raised to $53 from $42 at B. Riley FBR
06/03/20 Raymond James
Malibu Boats price target raised to $53 from $43 at Raymond James
05/18/20 B. Riley FBR
Malibu Boats price target raised to $42 from $33 at B. Riley FBR
MBUU Malibu Boats
$54.88 /

+3.5 (+6.81%)

Recommendations
Brunswick price target raised to $72 from $67 at KeyBanc » 07:09
07/07/20
07/07
07:09
07/07/20
07:09
BC

Brunswick

$65.75 /

+0.98 (+1.51%)

KeyBanc analyst Brett…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BC Brunswick
$65.75 /

+0.98 (+1.51%)

BC Brunswick
$65.75 /

+0.98 (+1.51%)

07/06/20 CL King
Brunswick price target raised to $79 from $52 at CL King
06/24/20 JPMorgan
JPMorgan says Brunswick thriving during social distancing, boosts target to $68
06/16/20 SunTrust
SunTrust raises 2020 marine retail volume forecast to down 5% to flat
06/11/20 KeyBanc
Brunswick price target raised to $67 from $55 at KeyBanc
BC Brunswick
$65.75 /

+0.98 (+1.51%)

BC Brunswick
$65.75 /

+0.98 (+1.51%)

Hot Stocks
Apellis completes enrollment in 2 Phase 3 studies of pegcetacoplan » 07:08
07/07/20
07/07
07:08
07/07/20
07:08
APLS

Apellis

$30.76 /

-2.2 (-6.67%)

Apellis Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APLS Apellis
$30.76 /

-2.2 (-6.67%)

APLS Apellis
$30.76 /

-2.2 (-6.67%)

06/16/20 BTIG
Apellis initiated with a Neutral at BTIG
06/12/20 Piper Sandler
Piper says competitive updates present 'very little' potential impact on Alexion
04/28/20 Cantor Fitzgerald
Apellis price target raised to $61 from $54 at Cantor Fitzgerald
04/01/20 Raymond James
Apellis initiated with a Strong Buy at Raymond James
APLS Apellis
$30.76 /

-2.2 (-6.67%)

  • 09
    Jan
APLS Apellis
$30.76 /

-2.2 (-6.67%)

Initiation
Slate Retail initiated with a Sector Perform at Scotiabank » 07:08
07/07/20
07/07
07:08
07/07/20
07:08
SRRTF

Slate Retail

$0.00 /

+ (+0.00%)

Scotiabank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRRTF Slate Retail
$0.00 /

+ (+0.00%)

05/20/20 RBC Capital
Slate Retail price target raised to $7 from $6.50 at RBC Capital
05/04/20 BMO Capital
Slate Retail price target lowered to C$6.50 from C$9 at BMO Capital
04/13/20 RBC Capital
Slate Retail price target lowered to C$6.50 from C$10 at RBC Capital
Hot Stocks
Zoetis, Trianni collaborate on transgenic monoclonal antibody platforms » 07:07
07/07/20
07/07
07:07
07/07/20
07:07
ZTS

Zoetis

$138.64 /

+1.07 (+0.78%)

Trianni and Zoetis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZTS Zoetis
$138.64 /

+1.07 (+0.78%)

ZTS Zoetis
$138.64 /

+1.07 (+0.78%)

06/08/20 Cleveland Research
Zoetis likely to bump up guidance, says Cleveland Research
05/27/20 Jefferies
Zoetis initiated with a Buy at Jefferies
05/15/20 Citi
Elanco price target lowered to $27 from $35 at Citi
05/07/20 Barclays
Zoetis price target raised to $140 from $129 at Barclays
ZTS Zoetis
$138.64 /

+1.07 (+0.78%)

ZTS Zoetis
$138.64 /

+1.07 (+0.78%)

Hot Stocks
Virtus Investment and Allianz Global Investors announce strategic partnership » 07:07
07/07/20
07/07
07:07
07/07/20
07:07
VRTS

Virtus Investment

$119.57 /

+5.66 (+4.97%)

Allianz Global Investors…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRTS Virtus Investment
$119.57 /

+5.66 (+4.97%)

VRTS Virtus Investment
$119.57 /

+5.66 (+4.97%)

06/15/20 Barclays
Virtus Investment price target raised to $118 from $105 at Barclays
05/04/20 Barclays
Virtus Investment price target raised to $105 from $95 at Barclays
02/18/20 Piper Sandler
Virtus Investment price target raised to $155 from $144 at Piper Sandler
02/03/20 Barclays
Barclays upgrades Virtus Investment to Overweight on recent momentum
VRTS Virtus Investment
$119.57 /

+5.66 (+4.97%)

Recommendations
UnitedHealth likely to reiterate 2020 outlook, says Cantor Fitzgerald » 07:07
07/07/20
07/07
07:07
07/07/20
07:07
UNH

UnitedHealth

$303.00 /

+4.96 (+1.66%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNH UnitedHealth
$303.00 /

+4.96 (+1.66%)

UNH UnitedHealth
$303.00 /

+4.96 (+1.66%)

07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
07/01/20 SVB Leerink
UnitedHealth reinstated with an Outperform at SVB Leerink
06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
UNH UnitedHealth
$303.00 /

+4.96 (+1.66%)

UNH UnitedHealth
$303.00 /

+4.96 (+1.66%)

UNH UnitedHealth
$303.00 /

+4.96 (+1.66%)

UNH UnitedHealth
$303.00 /

+4.96 (+1.66%)

Hot Stocks
Mesa Air reports 9,247 block hours in June » 07:06
07/07/20
07/07
07:06
07/07/20
07:06
MESA

Mesa Air

$3.36 /

+0.06 (+1.82%)

Mesa Air Group reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MESA Mesa Air
$3.36 /

+0.06 (+1.82%)

MESA Mesa Air
$3.36 /

+0.06 (+1.82%)

05/11/20 Raymond James
Mesa Air downgraded to Outperform from Strong Buy at Raymond James
05/11/20 Raymond James
Mesa Air downgraded to Outperform from Strong Buy at Raymond James
04/01/20 Stifel
Mesa Air downgraded to Hold from Buy at Stifel
03/25/20 Cowen
Mesa Air downgraded to Market Perform at Cowen
MESA Mesa Air
$3.36 /

+0.06 (+1.82%)

MESA Mesa Air
$3.36 /

+0.06 (+1.82%)

Hot Stocks
BioXcel Therapeutics receives notice of allowance for BXCL501 patent from USPTO » 07:06
07/07/20
07/07
07:06
07/07/20
07:06
BTAI

BioXcel Therapeutics

$47.92 /

-4.08 (-7.85%)

BioXcel Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$47.92 /

-4.08 (-7.85%)

BTAI BioXcel Therapeutics
$47.92 /

-4.08 (-7.85%)

06/05/20 Guggenheim
Guggenheim starts BioXcel Therapeutics at Buy on optimistic view of lead asset
06/04/20 Guggenheim
BioXcel Therapeutics initiated with a Buy at Guggenheim
04/01/20
Fly Intel: Top five analyst initiations
04/01/20 BofA
BioXcel Therapeutics initiated with a Buy at BofA
BTAI BioXcel Therapeutics
$47.92 /

-4.08 (-7.85%)

  • 20
    Feb
  • 26
    Sep
BTAI BioXcel Therapeutics
$47.92 /

-4.08 (-7.85%)

BTAI BioXcel Therapeutics
$47.92 /

-4.08 (-7.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.